Fetal Monitoring Market By Product (Ultrasound, Electronic Fetal Monitoring (EFM), Accessories and Consumables), By Method (Invasive, Non-Invasive), By Portability (Portable, Non-Portable), By Application (Intrapartum Fetal Monitoring, Antepartum Fetal Monitoring), By End User (Hospitals and Maternity Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The fetal monitoring market was valued at $3.4 billion in 2022 and is estimated to reach $6.2 billion by 2032, exhibiting a CAGR of 6.2% from 2023 to 2032. Fetal monitoring is a process that uses devices in prenatal care and childbirth. It involves the continuous or periodic monitoring of the fetus' heart rate and other relevant parameters to assess its well-being during pregnancy and labor. There are two main methods of fetal monitoring: electronic fetal monitoring (EFM) and ultrasound. During pregnancy and labor, healthcare providers routinely perform fetal monitoring to assess the well-being of the unborn baby (fetus). This procedure involves monitoring the baby's heart rate and other vital functions. Fetal monitoring is a widely practiced and essential procedure in prenatal care and childbirth.
The fetal monitoring market is driven by a rise in the number of preterm births, post-term pregnancy, and multiple pregnancy. For instance, the World Health Organization estimated that 13.4 million babies were born preterm in 2020 (before 37 completed weeks of gestation). In addition, non-invasive fetal monitoring techniques, such as doppler ultrasound and cardiotocography (CTG), are gaining popularity due to their safety and ease of use. These techniques eliminate the need for invasive procedures, thereby improving patient comfort and satisfaction. The increase in demand for non-invasive monitoring methods contributes to the growth of the fetal monitoring market. Furthermore, advancements in fetal monitoring devices propel the market growth. For instance, STAN monitor from Neoventa Medical and ACUSON S3000 ultrasound system from Siemens AG are few novel technologies for fetal heart monitoring. However, stringent regulatory procedures and high costs associated with these devices are anticipated to restrain market growth. Further, emerging technologies, such as portable and wireless products and untapped emerging economies offer lucrative opportunities for the market players.
The fetal monitoring market is segmented into product, method, portability, application, end user, and region. By product, the market is segregated into ultrasound, electronic fetal monitoring (EFM), and accessories and consumables. The ultrasound segment is further categorized into 2D ultrasound, 3D and 4D ultrasound, and doppler imaging. The electronic fetal monitoring (EFM) segment is further divided into external EFM and internal EFM. On the basis of method, the market is bifurcated into invasive and non-invasive. As per portability, it is classified into portable and non-portable. According to the application, it is divided into intrapartum fetal monitoring and antepartum fetal monitoring. Depending on the end user, the market is categorized into hospitals and maternity hospitals, clinics, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the fetal monitoring market are General Electric Company, MedGyn Products, Inc., EDAN Instrument, Inc., FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Siemens AG, Neoventa Medical AB, Natus Medical Incorporated, Arjo, and Cardinal Health Inc. Key players have adopted business expansion, product launch, and partnership as key developmental strategies to improve the product portfolio of the fetal monitoring market. For instance, in May 2023, Cardinal Health Canada announced the plans to open a new distribution center in the Greater Toronto Area (GTA), expanding its distribution footprint to nine strategic locations to better meet the medical and surgical product demands of the Canadian healthcare system.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the fetal monitoring market analysis from 2022 to 2032 to identify the prevailing fetal monitoring market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the fetal monitoring market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global fetal monitoring market trends, key players, market segments, application areas, and market growth strategies.
Key Market SegmentsBy ProductUltrasound
Type
2D Ultrasound
3D and 4D Ultrasound
Doppler Imaging
Electronic Fetal Monitoring (EFM)
Type
External EFM
Internal EFM
Accessories and Consumables
By MethodInvasive
Non-Invasive
By PortabilityPortable
Non-Portable
By ApplicationIntrapartum Fetal Monitoring
Antepartum Fetal Monitoring
By End UserOthers
Hospitals and Maternity Hospitals
Clinics
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
FUJIFILM Holdings Corporation
Koninklijke Philips N.V.
MedGyn products, inc.
Siemens AG
EDAN Instrument, Inc.
Natus Medical Incorporated.
Arjo
General Electric Company
Neoventa Medical AB
Cardinal Health Inc.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.